Pharma companies are striking deals with technology companies to gain access to their big data analytics to unlock information from patient health records about how medicines perform in the real world. It used to be hard to get information on how drugs work in routine clinical practice, but now we have electronic medical records and other databases which offer a wealth of patient-level data, or “real-world evidence.” (REUTERS)